{"title": "PDF", "author": "PDF", "url": "https://www.uab.edu/medicine/icos/images/POCC_Report/Bi-weekly_POCC_Report/Vaccine.12.16.2021.pdf", "hostname": "PDF", "description": "PDF", "sitename": "PDF", "date": "PDF", "cleaned_text": "Age: Median (Range) 16y (0-39) N % Gender Female 43 40% Race / Ethnicity Non -Hispanic White 50 46% Hispanic or Latino 26 24% Black 23 21% Insurance Public/Uninsured 28 25% Private 77 70% Vaccination Location Oncology Office 31 28% *To report cases, find the POCC report, a copy this report and FAQs, visit: https://www.uab.edu/medicine/icos/icos -research/the -pocc -report Allergic Reaction History History of Allergic Reaction 43 39% To Previous Vaccines 1 2% To Pegylated Asparaginase 13 30% ToEtoposide 0 0% Other 32 73%Median Days Between Last Chemotherapy and Vaccine : 15 days (IQR: 1-48)Patients, Vaccines, and Reactogenicity Local/Systemic Reactions: Chills, Fatigue, Fever, Headache, Injection Site Pain, Myalgias , Nausea, Vomiting "}